From: <Guardado por Windows Internet Explorer 8>
Subject: =?Windows-1252?Q?Trombosis_muy_tard=EDa_en_stent_met=E1lico_convencional.?=
	=?Windows-1252?Q?_Reporte_de_un_caso?=
Date: Thu, 3 Nov 2011 12:50:27 -0500
MIME-Version: 1.0
Content-Type: multipart/related;
	type="text/html";
	boundary="----=_NextPart_000_0019_01CC9A27.2950B960"
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2900.2180

This is a multi-part message in MIME format.

------=_NextPart_000_0019_01CC9A27.2950B960
Content-Type: text/html;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Content-Location: http://bvs.sld.cu/revistas/car/vol16_2_10/car11210.htm

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<!-- This HTML document was generated by PageMaker --><!-- On Mon May 31 =
04:12:52 2010 from "SINTITUL-2" --><HTML><HEAD><TITLE>Trombosis muy =
tard=EDa en stent met=E1lico convencional. Reporte de un caso</TITLE>
<META content=3D"text/html; charset=3Diso-8859-1" =
http-equiv=3DContent-Type>
<META name=3DGENERATOR content=3D"MSHTML 8.00.6001.18702"></HEAD>
<BODY bgColor=3D#ffffff>
<P align=3Dright><STRONG>Rev Cubana Cardiol Cir Cardiovasc=20
2010;16(2):197-200</STRONG></P>
<P align=3Dright><B><FONT size=3D2=20
face=3D"Verdana, Arial, Helvetica, sans-serif">PRESENTACI=D3N DE CASOS=20
</FONT></B></P>
<P align=3Dright>&nbsp;</P>
<P align=3Dleft><FONT size=3D4=20
face=3D"Verdana, Arial, Helvetica, sans-serif"><B>Trombosis muy tard=EDa =
en stent=20
met=E1lico convencional. Reporte de un caso</B></FONT></P>
<P align=3Dleft>&nbsp;</P>
<P align=3Dleft><FONT size=3D3 face=3D"Verdana, Arial, Helvetica, =
sans-serif"><B>Very=20
late thrombosis related to conventional metallic stent: A case=20
report</B></FONT></P>
<P align=3Dleft>&nbsp;</P>
<P align=3Dleft>&nbsp;</P>
<P align=3Dleft><FONT size=3D2=20
face=3D"Verdana, Arial, Helvetica, sans-serif"><STRONG>Dr. Abel Yoandri =
Leyva=20
Quert<SUP>I</SUP>; Tomas M=E9ndez Peralta<SUP>II</SUP>; Dr. Javier =
Almeida=20
G=F3mez<SUP>III</SUP>; Dr. Joel Brooks Tamayo<SUP>I</SUP>; Dr. Rogelio =
P=E9rez=20
Collado<SUP>I</SUP> </STRONG></FONT></P>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">I =
Especialista 1er.=20
Grado en Cardiolog=EDa. Hospital Hermanos Ameijeiras. Ciudad de la =
Habana. Cuba.=20
<BR></FONT><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, =
sans-serif">II</FONT>=20
<FONT size=3D2 face=3D"Verdana, Arial, Helvetica, =
sans-serif">Especialista 2do.=20
Grado en Cardiolog=EDa, Doctor en Ciencias M=E9dicas. Hospital Hermanos =
Ameijeiras.=20
Ciudad de la Habana. Cuba.<BR></FONT><FONT size=3D2=20
face=3D"Verdana, Arial, Helvetica, sans-serif">III. Especialista 2do. =
Grado en=20
Cardiolog=EDa. Hospital Hermanos Ameijeiras. Ciudad de la Habana. =
Cuba.<BR></FONT>
<P>
<P>
<HR SIZE=3D1 noShade>

<P><FONT size=3D2=20
face=3D"Verdana, Arial, Helvetica, sans-serif"><B>RESUMEN</B></FONT>=20
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">La =
trombosis muy=20
tard=EDa no es un fen=F3meno exclusivo de los stents farmacoactivos =
(DES); ha sido=20
descrita tambi=E9n, aunque raramente, luego de la implantaci=F3n de =
stents met=E1licos=20
convencionales (BMS) con consecuencias catastr=F3ficas para el paciente; =
la=20
etiolog=EDa no es bien conocida. Reportamos el caso de un paciente que =
present=F3 un=20
s=EDndrome coronario agudo sin elevaci=F3n del ST (SCASEST) de alto =
riesgo por=20
trombosis definitiva en un BMS luego de 39 meses de implantado. </FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, =
sans-serif"><B>Palabras clave:=20
</B>Stent, trombosis. </FONT>
<HR SIZE=3D1 noShade>

<P><FONT size=3D2=20
face=3D"Verdana, Arial, Helvetica, sans-serif"><B>ABSTRACT</B><BR><BR>A =
very late=20
thrombosis is an exclusive of pharmacoactive stents (DES) also has been=20
described although rarely after implantation of conventional metallic =
stents=20
(BMS) leading to catastrophic consequences for the patient; its etiology =
is not=20
well known. This the report of a patient with acute coronary syndrome =
without ST=20
rise (SCASEST) of high risk due to definitive thrombosis related to a =
BMS after=20
39 months of its implantation.<BR><BR><B>Key words:</B> Stent,=20
thrombosis</FONT>.</P>
<HR SIZE=3D1 noShade>

<P>&nbsp;</P>
<P>&nbsp;</P>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, =
sans-serif"><B><FONT=20
size=3D3>INTRODUCCI=D3N</FONT></B> </FONT></P>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">Los =
stents han=20
permitido optimizar los resultados del intervencionismo coronario =
percut=E1neo al=20
reducir el cierre abrupto del vaso tratado<SUP>1</SUP> y la incidencia =
de=20
reestenosis comparados con la angioplastia convencional con =
bal=F3n.<SUP>2,3</SUP>=20
Sin embargo, la trombosis del stent constituye un problema potencial y =
dram=E1tico=20
asociado a un 20-40% de mortalidad y un 70% de incidencia de infarto =
agudo del=20
miocardio (IAM),<SUP>4,5</SUP> que ocurre fundamentalmente los primeros =
30 d=EDas=20
tras la implantaci=F3n inicial de la endopr=F3tesis.<SUP>5-7</SUP> Con =
el=20
advenimiento de los stents liberadores de f=E1rmacos (Drug Eluting =
Stent-DES) un=20
nuevo fen=F3meno de trombosis muy tard=EDa (TMT) ha sido se=F1alado, =
debido=20
principalmente, a un retraso en la endotelizaci=F3n de los <FONT=20
color=3D#000000><EM>stents</EM></FONT> y potenciales caracter=EDsticas=20
protromb=F3ticas de los DES, la incidencia es de 0,4-0,6% por =
a=F1o.<SUP>8</SUP>=20
</FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">Aunque =
resulta una=20
complicaci=F3n infrecuente en los DES, la trombosis muy tard=EDa no es =
un fen=F3meno=20
exclusivo de los mismos, aunque muy raro, tambi=E9n ha sido reportado =
luego de la=20
implantaci=F3n de stents met=E1licos convencionales (Bare Metal =
Stent-BMS) fuera del=20
escenario de la braquiterapia.<SUP>9</SUP> </FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, =
sans-serif">Informamos un caso=20
de trombosis muy tard=EDa luego de 39 meses de implantado un BMS. =
</FONT>
<P>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, =
sans-serif"><B><FONT=20
size=3D3>PRESENTACI=D3N DEL CASO</FONT></B> </FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, =
sans-serif">Paciente masculino,=20
49 a=F1os, de la raza blanca, fumador por m=E1s de 30 a=F1os, que el 21 =
de agosto del=20
2006, en el contexto de un infarto agudo del miocardio sin elevaci=F3n =
del ST, se=20
le implant=F3 un stent met=E1lico convencional Apolo3 3,0/18 =
(Cordynamic,=20
Iberhospitex S. A), directo, a nivel de estenosis severa en segmento =
medio de la=20
arteria descendente anterior (DA), recibi=F3 doble terapia =
antiplaquetaria con=20
clopidogrel y aspirina durante un mes, continuando tratamiento con =
aspirina=20
oral. </FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">Se =
mantuvo=20
asintom=E1tico hasta el 15 de diciembre del 2009, cuando fue admitido en =
servicio=20
de urgencia de hospital municipal con el diagn=F3stico de s=EDndrome =
coronario agudo=20
sin elevaci=F3n del ST (SCASEST) de alto riesgo; en ECG mostraba =
inversi=F3n=20
sim=E9trica de la onda T de 3-6 mm desde V1 a V5, coordin=E1ndose su =
traslado a=20
nuestra instituci=F3n donde se le practic=F3 una angiograf=EDa coronaria =
que evidenci=F3=20
la presencia de trombo en borde proximal del stent y hasta 5 mm del =
mismo en=20
segmento proximal de la DA con flujo TIMI grado 2 del vaso epic=E1rdico; =
el stent=20
sin p=E9rdida luminal significativa, impresion=F3 moderadamente =
infraexpandido=20
(figura 1), la primera diagonal con origen precoz present=F3 lesi=F3n =
severa ostial=20
y en segmento proximal. En el resto de las arterias coronarias no se =
document=F3=20
estenosis angiogr=E1ficamente significativas, concluy=E9ndose como una =
trombosis=20
definitiva muy tard=EDa del stent convencional en DA. </FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">Se =
implant=F3 de=20
forma exitosa nuevo BMS Apolo3 de 3,5/ 23 (Cordynamic, Iberhospitex =
S.A),=20
directo, con inflado a 14 atm. </FONT>
<P>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, =
sans-serif"><B><FONT=20
size=3D3>DISCUSI=D3N </FONT></B></FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">La =
Academic=20
Research Consortium<SUP>10 </SUP>ha propuesto una clasificaci=F3n de la =
trombosis=20
del stent acorde con el tiempo y la certeza del diagn=F3stico (Tabla =
No.1),=20
considerando muy tard=EDa la ocurrida luego del a=F1o de implantaci=F3n =
y definitiva,=20
cuando se confirma angiogr=E1ficamente la presencia de trombo intrastent =
o dentro=20
de 5 mm del borde del dispositivo. En la literatura hasta el 2008, solo =
hay=20
reportado 23 casos, lo que demuestra la muy baja incidencia de la TMT =
definitiva=20
tras BMS.<SUP>11</SUP> </FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">Su =
mecanismo no ha=20
sido completamente aclarado. Una combinaci=F3n de factores pudieran =
estar=20
involucrados: larga longitud del stent, n=FAmero de stents implantados, =
arterias=20
coronarias peque=F1as, di=E1metro luminal m=EDnimo reducido =
postprocedimiento, stent=20
en lesi=F3n bifurcada, existencia de un =E1rea de bajo flujo entre el =
stent y la=20
pared del vaso, que ocurre cuando el stent no est=E1 completamente =
apuesto o en=20
presencia de disecci=F3n de la pared del vaso que limite el =
flujo.<SUP>12</SUP> La=20
reestenosis intrastent con severo estrechamiento puede conducir a la =
formaci=F3n=20
de trombo, igualmente la inflamaci=F3n cr=F3nica y la progresi=F3n de la =

ateroesclerosis en el interior del stent.<SUP>13,14</SUP> </FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">El =
endotelio=20
desempe=F1a un importante papel en la prevenci=F3n de la deposici=F3n =
del trombo<FONT=20
color=3D#0000ff>;</FONT> la implantaci=F3n de stents coronarios, =
invariablemente=20
produce una severa injuria endotelial. El tiempo requerido para que se=20
establezca una completa endotelizaci=F3n en humanos es desconocida<FONT=20
color=3D#0000ff>,</FONT> pero probablemente requiera, al menos, tres =
meses. A=20
pesar de que la cicatrizaci=F3n arterial provoca reestenosis cuando el =
crecimiento=20
neointimal es excesivo, una neo=EDntima rica en c=E9lulas musculares =
lisas=20
endotelizadas que sellan los componentes trombog=E9nicos desde la luz de =
la=20
arteria subyacente (stent met=E1lico, n=FAcleo lip=EDdico, fibrina), =
probablemente=20
proporciona protecci=F3n contra la TMT de los BMS.<SUP>13</SUP> </FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">Los =
hallazgos de=20
Asakura et al,<SUP>15</SUP> sugieren la regresi=F3n de neo=EDntima como =
posible=20
causa de TMT de los BMS, sus observaciones mediante angioscop=EDa =
demuestran un=20
adelgazamiento de la cubierta neointimal del stent durante el transcurso =
de los=20
tres a=F1os de haber sido implantado. </FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">Otros =
factores=20
mec=E1nicos como la mala posici=F3n tard=EDa del stent, la fractura y la =

infraexpansi=F3n se han propuesto como posibles causas de TMT tras=20
BMS.<SUP>16</SUP> En el caso presentado se puso de manifiesto en la=20
coronariograf=EDa una inadecuada expansi=F3n del stent que pudo estar =
vinculada con=20
el fen=F3meno tromb=F3tico que tuvo lugar. </FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">A pesar =
de que en=20
nuestro paciente no se recoge el antecedente de discontinuaci=F3n del =
tratamiento=20
con aspirina, no est=E1 clara si la suspensi=F3n de la terapia =
antiplaquetaria=20
desempe=F1a alg=FAn papel en la ocurrencia de la TMT del =
BMS.<SUP>11</SUP> </FONT>
<P><FONT color=3D#241f20 size=3D2 face=3D"Verdana, Arial, Helvetica, =
sans-serif">La=20
trombosis muy tard=EDa en los BMS se puede considerar anecd=F3tica, pero =
con=20
consecuencias catastr=F3ficas para el paciente, aunque sus mecanismos de =

producci=F3n no est=E1n del todo dilucidados</FONT><FONT color=3D#0000ff =
size=3D2=20
face=3D"Verdana, Arial, Helvetica, sans-serif">,</FONT><FONT =
color=3D#241f20 size=3D2=20
face=3D"Verdana, Arial, Helvetica, sans-serif"> se involucran factores=20
dependientes de la t=E9cnica lo que supone una mayor atenci=F3n del =
cardi=F3logo=20
intervencionista para lograr el mejor resultado final (<A=20
href=3D"http://bvs.sld.cu/revistas/car/vol16_2_10/car11210.htm#f01">Fig. =
1</A>)=20
(<A =
href=3D"http://bvs.sld.cu/revistas/car/vol16_2_10/car11210.htm#t01">Tabla=
=20
1</A>). </FONT>
<P align=3Dcenter><IMG src=3D"" width=3D592 height=3D440><A =
name=3Df01></A>=20
<P>
<P align=3Dcenter><IMG=20
src=3D"http://bvs.sld.cu/revistas/car/vol16_2_10/t0109210.gif" =
width=3D641=20
height=3D332><A name=3Dt01></A>=20
<P align=3Dcenter><A name=3Dt01></A>
<P>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, =
sans-serif"><B><FONT=20
size=3D3>REFERENCIAS BIBLIOGR=C1FICAS</FONT></B> </FONT>
<P><FONT color=3D#292526 size=3D2 face=3D"Verdana, Arial, Helvetica, =
sans-serif">1.=20
Roubin GS, Cannon AD, Agrawal SK, et al. Intracoronary stenting for =
acute and=20
threatened closure complicating percutaneous transluminal coronary =
angioplasty.=20
Circulation. 1992;85:916-927. <BR><BR></FONT><FONT color=3D#292526>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">2. =
Serruys PW, de=20
Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent=20
implantation with balloon angioplasty in patients with coronary artery =
disease.=20
Benestent Study Group. N Engl J Med. 1994;331:489-495. </FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">3. =
Fischman DL,=20
Leon MB, Baim DS, et al. A randomized comparison of coronary-stent =
placement and=20
balloon angioplasty in the treatment of coronary artery disease. Stent=20
Restenosis Study Investigators. N Engl J Med. 1994;331:496-501.</FONT> =
</FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">4. =
Kuchulakanti PK,=20
Chu WW, Torguson R, et al. Correlates and long-term outcomes of =
angiographically=20
proven stent thrombosis with sirolimus-and paclitaxel-eluting stents.=20
Circulation. 2006;113:1108-1113. </FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">5. =
Pinto Slottow=20
TL, Steinberg DH, Roy PK, et al. Observations and outcomes of definite =
and=20
probable drug-eluting stent thrombosis seen at a single hospital in a =
four-year=20
period. Am J Cardiol. 2008;102:298-303. </FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">6. =
Daemen J,=20
Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis =
of=20
sirolimus-eluting and paclitaxel-eluting stents in routine clinical =
practice:=20
Data from a large two-institutional cohort study. Lancet. =
2007;369:667-678.=20
</FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">7. Ong =
AT, Hoye A,=20
Aoki J, et al. Thirty-day incidence and six-month clinical outcome of =
thrombotic=20
stent occlusion after bare-metal, sirolimus, or paclitaxel stent =
implantation. J=20
Am Coll Cardiol. 2005;45:947-953. </FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">8. =
Karvouni E,=20
Korovesis S, Katritsis DG. Very late thrombosis after implantation of =
sirolimus=20
eluting stent. Heart. 2005;91:e45. </FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">9. =
Celik T, Iyisoy=20
A, Celik M, Isik E. A case of very late stent thrombosis after bare =
metal=20
coronary stent implantation: A neglected complication. Int J Cardiol. =
2007, Dec=20
3. </FONT>
<P><FONT color=3D#231f20 size=3D2 face=3D"Verdana, Arial, Helvetica, =
sans-serif">10.=20
U. S. Food and Drug Administration CDRH. Update to FDA Statement on =
Coronary=20
Drug-Eluting Stents. </FONT><FONT size=3D2=20
face=3D"Verdana, Arial, Helvetica, sans-serif">2007.<FONT =
color=3D#231f20> Available=20
at: </FONT></FONT><FONT color=3D#000064 size=3D2=20
face=3D"Verdana, Arial, Helvetica, sans-serif"><A=20
href=3D"http://bvs.sld.cu/www.fda.gov/cdrh/news/010407.html">http:/www.fd=
a.gov/cdrh/news/010407.html</A></FONT>=20

<P><FONT color=3D#292526 size=3D2 face=3D"Verdana, Arial, Helvetica, =
sans-serif">11.=20
Lemesle G, Pinto T, Waksman R. </FONT><FONT size=3D2=20
face=3D"Verdana, Arial, Helvetica, sans-serif">Very Late Stent =
Thrombosis after=20
Bare-Metal Stent Implantation: Case Reports and Review of the =
Literature.=20
<U><FONT color=3D#0000ff><A=20
href=3D"http://bvs.sld.cu/revistas/car/vol16_2_10/JInvasive%20Cardiol.">J=
 Invasive=20
Cardiol.</A></FONT></U> 2009 Feb;21(2):27-32. </FONT>
<P><FONT color=3D#241f20 size=3D2 face=3D"Verdana, Arial, Helvetica, =
sans-serif">12.=20
Wenaweser P, Rey C, Eberli FR, et al. Stent thrombosis following =
bare-metal=20
stent implantation; success of emergency percutaneous coronary =
intervention and=20
predictors of adverse outcome. Eur Heart J. 2005;26:1180-1187.</FONT>=20
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">13. =
Farb A, Burke=20
AP, Kolodgie FD, et al. Pathological mechanisms of fatal late coronary =
stent=20
thrombosis in humans. Circulation. 2003;108:1701-1706. </FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">14. =
Hasegawa K,=20
Tamai H, Kyo E, et al. Histopathological findings of new in-stent =
lesions=20
developed beyond five years. Catheter Cardiovasc Interv. =
2006;68:554-558.=20
</FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">15. =
Asakura M, Ueda=20
Y, Nanto S, et al. Remodeling of in-stent neointima, which became =
thinner and=20
transparent over 3 years: Serial angiographic and angioscopic follow-up. =

Circulation. 1998;97:2003-2006. </FONT>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, sans-serif">16. =
Hayashi T,=20
Kimura A, Ishikawa K. Acute myocardial infarction caused by thrombotic =
occlusion=20
at a stent site two years after conventional stent implantation. Heart.=20
2004;90:e26. </FONT>
<P align=3Dleft><FONT size=3D2=20
face=3D"Verdana, Arial, Helvetica, sans-serif">Recibido: </FONT><FONT =
size=3D2=20
face=3D"Verdana, Geneva, sans-serif">26 de Marzo de 2010</FONT></P>
<P align=3Dleft><FONT size=3D2=20
face=3D"Verdana, Arial, Helvetica, sans-serif">Aceptado: </FONT><FONT =
size=3D2=20
face=3D"Verdana, Geneva, sans-serif">3 de Mayo de 2010</FONT></P>
<P align=3Dright>&nbsp;</P>
<P>
<P><FONT size=3D2 face=3D"Verdana, Arial, Helvetica, =
sans-serif">Correspondencia:=20
Dr. Abel Leyva Quert.</FONT> <BR><FONT size=3D2=20
face=3D"Verdana, Arial, Helvetica, sans-serif">Correo electr=F3nico:=20
aquert@infomed.sld.cu</FONT>=20
<P></P></BODY></HTML>

------=_NextPart_000_0019_01CC9A27.2950B960
Content-Type: application/octet-stream
Content-Transfer-Encoding: base64
Content-Location: http://bvs.sld.cu/revistas/car/vol16_2_10/t0109210.gif
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=

------=_NextPart_000_0019_01CC9A27.2950B960--
